Cargando…

Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma Patient-centred Intervention Network (SPIN) Cohort Study

OBJECTIVES: The Social Appearance Anxiety Scale (SAAS) is a 16-item questionnaire developed to evaluate fear of appearance-based evaluation by others. The primary objective of this research was to investigate the existence of differential item functioning (DIF) for the 16 SAAS items, comparing patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommer, Sophia J, Harel, Daphna, Kwakkenbos, Linda, Carrier, Marie-Eve, Gholizadeh, Shadi, Gottesman, Karen, Leite, Catarina, Malcarne, Vanessa L, Thombs, Brett D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552836/
https://www.ncbi.nlm.nih.gov/pubmed/33046467
http://dx.doi.org/10.1136/bmjopen-2020-037639
_version_ 1783593484011175936
author Sommer, Sophia J
Harel, Daphna
Kwakkenbos, Linda
Carrier, Marie-Eve
Gholizadeh, Shadi
Gottesman, Karen
Leite, Catarina
Malcarne, Vanessa L
Thombs, Brett D
author_facet Sommer, Sophia J
Harel, Daphna
Kwakkenbos, Linda
Carrier, Marie-Eve
Gholizadeh, Shadi
Gottesman, Karen
Leite, Catarina
Malcarne, Vanessa L
Thombs, Brett D
author_sort Sommer, Sophia J
collection PubMed
description OBJECTIVES: The Social Appearance Anxiety Scale (SAAS) is a 16-item questionnaire developed to evaluate fear of appearance-based evaluation by others. The primary objective of this research was to investigate the existence of differential item functioning (DIF) for the 16 SAAS items, comparing patients who completed the SAAS in English and French, either to confirm that scores are comparable or provide guidance on calculating comparable scores. A secondary research objective was to investigate the existence of DIF based on sex and disease status. A tertiary research objective was to assess DIF related to language, sex, and disease status on the recently developed SAAS-5. DESIGN: This was a cross-sectional analysis using baseline data from patients enrolled in the Scleroderma Patient-centred Intervention Network (SPIN). SETTING: SPIN patients included in the present study were enrolled at 43 centres in Canada, USA, UK, France and Australia, with questionnaires completed in April 2014 to July 2019. PARTICIPANTS: 1640 SPIN patients completed the SAAS in French (n=600) or English (n=1040). PRIMARY AND SECONDARY MEASURES: The SAAS was collected along with demographic and disease characteristics. RESULTS: Six items were identified with statistically significant language-based DIF, four with sex-based DIF and one with disease type-based DIF. However, factor scores before and after accounting for DIF were similar (Pearson correlation >0.99), and individual score differences were small. This was true for both the full and shortened versions of the SAAS. CONCLUSION: SAAS and SAAS-5 scores are comparable across language, sex, and disease-type, despite small differences in how patients respond to some items.
format Online
Article
Text
id pubmed-7552836
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75528362020-10-21 Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma Patient-centred Intervention Network (SPIN) Cohort Study Sommer, Sophia J Harel, Daphna Kwakkenbos, Linda Carrier, Marie-Eve Gholizadeh, Shadi Gottesman, Karen Leite, Catarina Malcarne, Vanessa L Thombs, Brett D BMJ Open Research Methods OBJECTIVES: The Social Appearance Anxiety Scale (SAAS) is a 16-item questionnaire developed to evaluate fear of appearance-based evaluation by others. The primary objective of this research was to investigate the existence of differential item functioning (DIF) for the 16 SAAS items, comparing patients who completed the SAAS in English and French, either to confirm that scores are comparable or provide guidance on calculating comparable scores. A secondary research objective was to investigate the existence of DIF based on sex and disease status. A tertiary research objective was to assess DIF related to language, sex, and disease status on the recently developed SAAS-5. DESIGN: This was a cross-sectional analysis using baseline data from patients enrolled in the Scleroderma Patient-centred Intervention Network (SPIN). SETTING: SPIN patients included in the present study were enrolled at 43 centres in Canada, USA, UK, France and Australia, with questionnaires completed in April 2014 to July 2019. PARTICIPANTS: 1640 SPIN patients completed the SAAS in French (n=600) or English (n=1040). PRIMARY AND SECONDARY MEASURES: The SAAS was collected along with demographic and disease characteristics. RESULTS: Six items were identified with statistically significant language-based DIF, four with sex-based DIF and one with disease type-based DIF. However, factor scores before and after accounting for DIF were similar (Pearson correlation >0.99), and individual score differences were small. This was true for both the full and shortened versions of the SAAS. CONCLUSION: SAAS and SAAS-5 scores are comparable across language, sex, and disease-type, despite small differences in how patients respond to some items. BMJ Publishing Group 2020-10-12 /pmc/articles/PMC7552836/ /pubmed/33046467 http://dx.doi.org/10.1136/bmjopen-2020-037639 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research Methods
Sommer, Sophia J
Harel, Daphna
Kwakkenbos, Linda
Carrier, Marie-Eve
Gholizadeh, Shadi
Gottesman, Karen
Leite, Catarina
Malcarne, Vanessa L
Thombs, Brett D
Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma Patient-centred Intervention Network (SPIN) Cohort Study
title Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma Patient-centred Intervention Network (SPIN) Cohort Study
title_full Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma Patient-centred Intervention Network (SPIN) Cohort Study
title_fullStr Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma Patient-centred Intervention Network (SPIN) Cohort Study
title_full_unstemmed Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma Patient-centred Intervention Network (SPIN) Cohort Study
title_short Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma Patient-centred Intervention Network (SPIN) Cohort Study
title_sort assessing differential item functioning for the social appearance anxiety scale: a scleroderma patient-centred intervention network (spin) cohort study
topic Research Methods
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552836/
https://www.ncbi.nlm.nih.gov/pubmed/33046467
http://dx.doi.org/10.1136/bmjopen-2020-037639
work_keys_str_mv AT sommersophiaj assessingdifferentialitemfunctioningforthesocialappearanceanxietyscaleasclerodermapatientcentredinterventionnetworkspincohortstudy
AT hareldaphna assessingdifferentialitemfunctioningforthesocialappearanceanxietyscaleasclerodermapatientcentredinterventionnetworkspincohortstudy
AT kwakkenboslinda assessingdifferentialitemfunctioningforthesocialappearanceanxietyscaleasclerodermapatientcentredinterventionnetworkspincohortstudy
AT carriermarieeve assessingdifferentialitemfunctioningforthesocialappearanceanxietyscaleasclerodermapatientcentredinterventionnetworkspincohortstudy
AT gholizadehshadi assessingdifferentialitemfunctioningforthesocialappearanceanxietyscaleasclerodermapatientcentredinterventionnetworkspincohortstudy
AT gottesmankaren assessingdifferentialitemfunctioningforthesocialappearanceanxietyscaleasclerodermapatientcentredinterventionnetworkspincohortstudy
AT leitecatarina assessingdifferentialitemfunctioningforthesocialappearanceanxietyscaleasclerodermapatientcentredinterventionnetworkspincohortstudy
AT malcarnevanessal assessingdifferentialitemfunctioningforthesocialappearanceanxietyscaleasclerodermapatientcentredinterventionnetworkspincohortstudy
AT thombsbrettd assessingdifferentialitemfunctioningforthesocialappearanceanxietyscaleasclerodermapatientcentredinterventionnetworkspincohortstudy
AT assessingdifferentialitemfunctioningforthesocialappearanceanxietyscaleasclerodermapatientcentredinterventionnetworkspincohortstudy